MISHA is described as the world’s first implantable shock absorber for the knee, and is based on the benefits of weight load reduction on diseased joints.
Regenexx published its randomized controlled trial (RCT) mid-term results showing primary anterior cruciate ligament (ACL) healing without the need for...